https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
277
 
downloads
46
CITE
How to cite this poster:
Griebel G, Pichat P, Beeske S et al. Glycogen synthase kinase-3-beta (GSK-3-beta) inhibition as a promising drug target for the treatment of comorbid Alzheimer's disease or schizophrenia, and depression. F1000Posters 2013, 4:1421 (poster)

Glycogen synthase kinase-3-beta (GSK-3-beta) inhibition as a promising drug target for the treatment of comorbid Alzheimer's disease or schizophrenia, and depression

Guy Griebel1, P Pichat, S Beeske, D Boulay, M Lopez-Grancha, J Stemmelin, C Cohen, G Boquet, P Avenet, O Curet
Published 10 Dec 2013
Author Affiliations
  • Metrics
  • 277 Views
  • 46 Downloads
Browse by related subjects
Published 10 Dec 2013

Glycogen synthase kinase-3-beta (GSK-3-beta) inhibition as a promising drug target for the treatment of comorbid Alzheimer's disease or schizophrenia, and depression

[version 1; not peer reviewed]

Guy Griebel1, P Pichat, S Beeske, D Boulay, M Lopez-Grancha, J Stemmelin, C Cohen, G Boquet, P Avenet, O Curet
Author Affiliations
1 Exploratory Unit, Sanofi, France
Presented at
Neuroscience 2013
Abstract
Competing Interests

No competing interests were disclosed

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.